13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuroethicists
Neuroethicists explore the ethical implications of neuroscience and neurotechnology, focusing on issues related to brain research, cognitive enhancement, and the treatment of neurological disorders. Their work involves addressing questions about consent, autonomy, and privacy in the context of neuroscience, as well as the responsible use of emerging technologies such as brain-machine interfaces and neurogenetic modifications. Neuroethicists analyze how advances in neuroimaging, neuroprosthetics, and deep brain stimulation challenge traditional ethical frameworks. They are concerned with the societal impact of these technologies, including the potential for inequality or misuse. Neuroethicists play an essential role in guiding policy and regulation by providing insights into the ethical considerations surrounding issues like brain enhancement, neurodegenerative disease treatment, and cognitive liberty. In addition to working with scientists, clinicians, and policymakers, neuroethicists engage with the public to foster dialogue about the implications of neuroscience in society. Their research also delves into questions about the nature of consciousness, identity, and free will in the context of neurological disorders and treatments. By critically examining these issues, neuroethicists aim to ensure that advances in neuroscience are applied in ethically sound ways that benefit both individuals and society.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States